by George Ciuciureanu | Oct 28, 2025 | Health, News
The U.S. FDA has granted Breakthrough Device Designation to SPINEstat® (14-3-3eta Autoantibody Multiplex Immunoassay Test), recognizing its potential to address a significant unmet need in the diagnosis of patients with axial spondyloarthritis (axSpA). SPINEstat®,...
by George Ciuciureanu | Oct 22, 2025 | Health, News
Vancouver, Canada – October 22, 2025 — Augurex Life Sciences, a leader in autoimmune biomarker-based diagnostics, today announced that AiArthritis has launched a new patient education feature focused on the 14-3-3eta blood test in rheumatoid arthritis (RA)....
by George Ciuciureanu | Oct 17, 2025 | Events, Health
Vancouver, Canada – October 17, 2025 – Augurex Life Sciences, a leader in autoimmune biomarker-based diagnostics, today announced that it will be exhibiting at Booth 919 and presenting new data at the American College of Rheumatology (ACR) Convergence 2025, taking...
by George Ciuciureanu | Oct 15, 2025 | Events, Health
Augurex has partnered with MitogenDx to expand access to JOINTstat® testing across Canada, improving physician and patient access to advanced tools for rheumatoid arthritis (RA) diagnosis and monitoring. JOINTstat® is a Health Canada-approved Class II in vitro...
by George Ciuciureanu | Sep 24, 2025 | Events, Health
Augurex to present new data from clinical studies in an oral presentation and two poster presentations at ACR Convergence 2025, taking place October 24 – 29 in Chicago, IL. Professor Raj Sengupta will present new data in on the use of autoantibodies to 14-3-3eta in...
by George Ciuciureanu | Sep 8, 2025 | Events, Health
Vancouver, Canada – September 8, 2025 – Augurex Life Sciences, a leader in autoimmune biomarker-based diagnostics, today announced it will exhibit and present new data at the Congress of Clinical Rheumatology West (CCR West) 2025, taking place September 18–21 in...
